BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33485832)

  • 1. The
    Bergesio F; De Maggi A; Coronado M; Pardal E; Plaza R; Hernández AC; Sarandeses MDP; Cortes M; Setoain X; Simó M; Rotger A; Grande C; Caballero MD; Chauvie S
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(3):149-154. PubMed ID: 33485832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).
    Chauvie S; Bergesio F; Fioroni F; Brambilla M; Biggi A; Versari A; Guerra L; Storto G; Musto P; Luminari S; Cabras MG; Balzarotti M; Rigacci L; Martelli M; Vitolo U; Federico M; Gallamini A
    Phys Med; 2016 May; 32(5):651-6. PubMed ID: 27133138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of international prognostic index, revised international prognostic index, enhanced international prognostic index and Grupo Español de Linfomas/trasplante autólogo de médula ósea-international prognostic index for diffuse large B-cell lymphoma].
    Feng YX; Su LP
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):949-954. PubMed ID: 33256307
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.
    Hong J; Kim SJ; Chang MH; Kim JA; Kwak JY; Kim JS; Yoon DH; Lee WS; Do YR; Kang HJ; Eom HS; Park Y; Won JH; Mun YC; Kim HJ; Kwon JH; Kong JH; Oh SY; Lee S; Bae SH; Yang DH; Jun HJ; Lee HS; Yun HJ; Lee SI; Kim MK; Yi JH; Lee JH; Kim WS; Suh C
    Oncotarget; 2017 Nov; 8(54):92171-92182. PubMed ID: 29190906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution.
    Salas MQ; Mercadal S; Domingo Domenech E; Oliveira AC; Encuentra M; Climent F; Andrade Campos M; Aguilera C; Fernández de Sevilla A; Sureda A; González-Barca E
    Leuk Lymphoma; 2020 Mar; 61(3):575-581. PubMed ID: 31684781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH).
    González-Vicent M; Sanz J; Fuster JL; Cid J; de Heredia CD; Morillo D; Fernández JM; Pascual A; Badell I; Serrano D; Fox L; de la Serna J; Benito A; Couselo JM; Molina B; Díaz MÁ; Sanz MÁ
    Transfus Med Rev; 2018 Mar; ():. PubMed ID: 29573905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.
    Sureda A; Arranz R; Iriondo A; Carreras E; Lahuerta JJ; García-Conde J; Jarque I; Caballero MD; Ferrà C; López A; García-Laraña J; Cabrera R; Carrera D; Ruiz-Romero MD; León A; Rifón J; Díaz-Mediavilla J; Mataix R; Morey M; Moraleda JM; Altés A; López-Guillermo A; de la Serna J; Fernández-Rañada JM; Sierra J; Conde E;
    J Clin Oncol; 2001 Mar; 19(5):1395-404. PubMed ID: 11230484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total-body
    Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are lesion features reproducible between
    Constantino CS; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz SC; Vieira P; Costa DC
    Eur Radiol; 2021 May; 31(5):3071-3079. PubMed ID: 33125562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
    Satoh Y; Motosugi U; Imai M; Onishi H
    Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
    Magnano L; Alonso-Alvarez S; Alcoceba M; Rivas-Delgado A; Muntañola A; Nadeu F; Setoain X; Rodríguez S; Andrade-Campos M; Espinosa-Lara N; Rodríguez G; Sancho JM; Moreno M; Mercadal S; Carro I; Salar A; Garcia-Pallarols F; Arranz R; Cannata J; Terol MJ; Teruel AI; Jiménez-Ubieto A; Rodriguez A; González de Villambrosía S; Bello JL; López L; Novelli S; de Cabo E; Infante ME; Pardal E; Monsalvo S; González M; Martín A; Caballero MD; López-Guillermo A;
    Br J Haematol; 2019 May; 185(3):480-491. PubMed ID: 30793290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
    Montalbán C; Díaz-López A; Martín A; Baile M; Sanchez JM; Sancho JM; García O; Novelli S; Monter-Rovira A; Salar A; Bastos M; Gutiérrez A; Bento L; Córdoba R; Arquero T; González de Villambrosia S; Barranco G; De Oña R; López Guillermo A; Rodriguez Salazar MJ; Domínguez JF; Fernández R; Queizan JA; Rodríguez J; Abraira V; García JF;
    Br J Haematol; 2018 Aug; 182(4):534-541. PubMed ID: 29978453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma.
    Daisaki H; Tateishi U; Terauchi T; Tatsumi M; Suzuki K; Shimada N; Nishida H; Numata A; Kato K; Akashi K; Harada M
    Ann Nucl Med; 2013 Apr; 27(3):225-32. PubMed ID: 23264065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study.
    Tsutsui Y; Daisaki H; Akamatsu G; Umeda T; Ogawa M; Kajiwara H; Kawase S; Sakurai M; Nishida H; Magota K; Mori K; Sasaki M;
    EJNMMI Res; 2018 Aug; 8(1):83. PubMed ID: 30128776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of
    Pfaehler E; Beukinga RJ; de Jong JR; Slart RHJA; Slump CH; Dierckx RAJO; Boellaard R
    Med Phys; 2019 Feb; 46(2):665-678. PubMed ID: 30506687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β
    Montalbán C; Díaz-López A; Dlouhy I; Rovira J; Lopez-Guillermo A; Alonso S; Martín A; Sancho JM; García O; Sánchez JM; Rodríguez M; Novelli S; Salar A; Gutiérrez A; Rodríguez-Salazar MJ; Bastos M; Domínguez JF; Fernández R; Gonzalez de Villambrosia S; Queizan JA; Córdoba R; de Oña R; López-Hernandez A; Freue JM; Garrote H; López L; Martin-Moreno AM; Rodriguez J; Abraira V; García JF;
    Br J Haematol; 2017 Mar; 176(6):918-928. PubMed ID: 28106247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.
    Salar A; Domingo-Domenech E; Panizo C; Nicolás C; Bargay J; Muntañola A; Canales M; Bello JL; Sancho JM; Tomás JF; Rodríguez MJ; Peñalver FJ; Grande C; Sánchez-Blanco JJ; Palomera L; Arranz R; Conde E; García M; García JF; Caballero D; Montalbán C;
    Lancet Haematol; 2014 Dec; 1(3):e104-11. PubMed ID: 27029228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.
    Beichel RR; Smith BJ; Bauer C; Ulrich EJ; Ahmadvand P; Budzevich MM; Gillies RJ; Goldgof D; Grkovski M; Hamarneh G; Huang Q; Kinahan PE; Laymon CM; Mountz JM; Muzi JP; Muzi M; Nehmeh S; Oborski MJ; Tan Y; Zhao B; Sunderland JJ; Buatti JM
    Med Phys; 2017 Feb; 44(2):479-496. PubMed ID: 28205306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
    Alonso-Álvarez S; Magnano L; Alcoceba M; Andrade-Campos M; Espinosa-Lara N; Rodríguez G; Mercadal S; Carro I; Sancho JM; Moreno M; Salar A; García-Pallarols F; Arranz R; Cannata J; Terol MJ; Teruel AI; Rodríguez A; Jiménez-Ubieto A; González de Villambrosia S; Bello JL; López L; Monsalvo S; Novelli S; de Cabo E; Infante MS; Pardal E; García-Álvarez M; Delgado J; González M; Martín A; López-Guillermo A; Caballero MD
    Br J Haematol; 2017 Sep; 178(5):699-708. PubMed ID: 28782811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.